Celesio AG 25.10.2013 11:39 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- On October 23, 2013, BlackRock Holdo 2, Inc., Wilmington, DE, U.S.A. has informed us according to Article 21, Section 1 of the WpHG that via shares its Voting Rights on Celesio AG, Stuttgart, Deutschland, have fallen below the 3% threshold of the Voting Rights on October 22, 2013 and on that day amounted to 2.96% (this corresponds to 5028956 Voting Rights). According to Article 22, Section 1, Sentence 1, No. 6 in connection with sentence 2 of the WpHG, 2.96% of the Voting Rights (this corresponds to 5028956 Voting Rights) is to be attributed to the company. 25.10.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Celesio AG Neckartalstr. 155 70376 Stuttgart Germany Internet: www.celesio.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: Celesio AG: Release according to Article 26,
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Scorpius Holdings Boosts Efficiency with New Cost Reduction Plan
Scorpius Holdings Implements Significant Cost-Saving Strategies Scorpius Holdings, Inc. (NYSE American: SCPX), a notable player in the biomanufacturing landscape, has recently introduced a series of strategic cost-saving measures. These initiatives aim to reduce operational costs by more than $2 million annually, showcasing the company's commitment to enhancing its...
Continue Reading
McKesson's Strategic Shift: Selling Rexall and Well.ca
McKesson Corporation Expands Focus on Healthcare Services IRVING, Texas - McKesson Corporation (NYSE: MCK), a leader in healthcare services with a market capitalization of $72.45 billion and annual revenue exceeding $330 billion, has officially completed the sale of its Rexall and Well.ca businesses to Birch Hill Equity Partners. This noteworthy decision allows McKesson...
Continue Reading
GSI Group Enhances Market with GenesisBPS Acquisition
GSI Group Strengthens Its Portfolio GSI Group Holdings has made a significant move by acquiring GenesisBPS, an innovative designer and manufacturer of specialized benchtop blood processing equipment and laboratory consumables. This acquisition enhances GSI Group's expanding global sales platform, reinforcing its commitment to serving the life sciences, research and...
Continue Reading
Forecasting Growth in the Antidepressant Drugs Market
Understanding the Antidepressant Drugs Market The Antidepressant Drugs Market is anticipated to undergo significant growth, with a projection to reach USD 26.9 billion by 2033. This upward trend reflects a compound annual growth rate (CAGR) of 3.3% from 2024 to 2033, highlighting the increasing reliance on these medications to treat depression. Antidepressants are...
Continue Reading
Inceptio Technology Introduces Strategic Vision for L4 Trucks
A Visionary Approach to L4 Autonomous Trucking by Inceptio Technology Inceptio Technology is making significant strides in the field of autonomous trucking, sharing its detailed strategy for scaling Level 4 (L4) autonomous trucks. The company recently took center stage at the Next Truck 2025 conference, demonstrating its commitment to reshaping the future of...
Continue Reading